{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T04:49:19Z","timestamp":1768970959072,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T00:00:00Z","timestamp":1329177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T00:00:00Z","timestamp":1329177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00134-012-2484-5","type":"journal-article","created":{"date-parts":[[2012,2,13]],"date-time":"2012-02-13T16:51:46Z","timestamp":1329151906000},"page":"1050-1060","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Haemodynamic and neuroendocrine effects of tezosentan in chronic experimental pulmonary hypertension"],"prefix":"10.1007","volume":"38","author":[{"given":"Andr\u00e9 P.","family":"Louren\u00e7o","sequence":"first","affiliation":[]},{"given":"Francisco","family":"Vasques-N\u00f3voa","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Oliveira-Pinto","sequence":"additional","affiliation":[]},{"given":"Dulce","family":"Fontoura","sequence":"additional","affiliation":[]},{"suffix":"Jr.","given":"Roberto","family":"Roncon-Albuquerque","sequence":"additional","affiliation":[]},{"given":"Adelino F.","family":"Leite-Moreira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,2,14]]},"reference":[{"key":"2484_CR1","doi-asserted-by":"publisher","unstructured":"Lourenco AP, Fontoura D, Henriques-Coelho T, Leite-Moreira AF (2011) Current pathophysiological concepts and management of pulmonary hypertension. Int J Cardiol. doi:10.1016\/j.ijcard.2011.05.066","DOI":"10.1016\/j.ijcard.2011.05.066"},{"key":"2484_CR2","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1164\/rccm.200901-0136UP","volume":"179","author":"M Humbert","year":"2009","unstructured":"Humbert M (2009) Update in pulmonary hypertension 2008. Am J Respir Crit Care Med 179:650\u2013656","journal-title":"Am J Respir Crit Care Med"},{"key":"2484_CR3","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.annfar.2005.02.022","volume":"24","author":"F Kerbaul","year":"2005","unstructured":"Kerbaul F, Rondelet B, Collart F, Naeije R, Gouin F (2005) [Pulmonary arterial hypertension in intensive care unit and operating room]. Ann Fr Anesth Reanim 24:528-540. Epub 2005 Apr 2012","journal-title":"Ann Fr Anesth Reanim"},{"key":"2484_CR4","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1164\/rccm.2503002","volume":"171","author":"VV McLaughin","year":"2005","unstructured":"McLaughin VV, Hoeper MM (2005) Pulmonary arterial hypertension: the race for the most effective treatment. Am J Respir Crit Care Med 171:1199\u20131201","journal-title":"Am J Respir Crit Care Med"},{"key":"2484_CR5","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0022-3565(24)34972-9","volume":"290","author":"M Clozel","year":"1999","unstructured":"Clozel M, Ramuz H, Clozel JP, Breu V, Hess P, L\u00f6ffler BM, Coassolo P, Roux S (1999) Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use. J Pharmacol Exp Ther 290:840\u2013847","journal-title":"J Pharmacol Exp Ther"},{"key":"2484_CR6","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1097\/01.CCM.0000280433.74246.9E","volume":"35","author":"RT Zamanian","year":"2007","unstructured":"Zamanian RT, Haddad F, Doyle RL, Weinacker AB (2007) Management strategies for patients with pulmonary hypertension in the intensive care unit. Crit Care Med 35:2037\u20132050","journal-title":"Crit Care Med"},{"key":"2484_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00134-007-0831-8","volume":"34","author":"S Rex","year":"2008","unstructured":"Rex S, Missant C, Segers P, Rossaint R, Wouters PF (2008) Epoprostenol treatment of acute pulmonary hypertension is associated with a paradoxical decrease in right ventricular contractility. Intensive Care Med 34:179\u2013189","journal-title":"Intensive Care Med"},{"key":"2484_CR8","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s00134-010-1754-3","volume":"36","author":"AD Cornet","year":"2010","unstructured":"Cornet AD, Hofstra JJ, Swart EL, Girbes AR, Juffermans NP (2010) Sildenafil attenuates pulmonary arterial pressure but does not improve oxygenation during ARDS. Intensive Care Med 36:758\u2013764","journal-title":"Intensive Care Med"},{"key":"2484_CR9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.pharmthera.2005.11.001","volume":"111","author":"F Brunner","year":"2006","unstructured":"Brunner F, Bras-Silva C, Cerdeira AS, Leite-Moreira AF (2006) Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol Ther 111:508\u2013531. Epub 2006 Feb 2002.","journal-title":"Pharmacol Ther"},{"key":"2484_CR10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.CIR.101.2.142","volume":"101","author":"PA MacCarthy","year":"2000","unstructured":"MacCarthy PA, Grocott-Mason R, Prendergast BD, Shah AM (2000) Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart: studies with an intracoronary ET(A) receptor antagonist. Circulation 101:142\u2013147","journal-title":"Circulation"},{"key":"2484_CR11","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/01.CCM.0000114575.08269.F6","volume":"32","author":"V Kuklin","year":"2004","unstructured":"Kuklin V, Kirov MY, Evgenov OV, Sovershaev MA, Sj\u00f6berg J, Kirova SS, Bjertnaes LJ (2004) Novel endothelin receptor antagonist attenuates endotoxin-induced lung injury in sheep. Crit Care Med 32:766\u2013773","journal-title":"Crit Care Med"},{"key":"2484_CR12","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1152\/japplphysiol.01139.2005","volume":"102","author":"J Tsang","year":"2007","unstructured":"Tsang J, Lamm WJ, Neradilek B, Polissar NL, Hlastala MP (2007) Endothelin receptor blockade does not improve hypoxemia following acute pulmonary thromboembolism. J Appl Physiol 102:762\u2013771","journal-title":"J Appl Physiol"},{"key":"2484_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s00134-007-0857-y","volume":"34","author":"R Geiger","year":"2008","unstructured":"Geiger R, Kleinsasser A, Meier S, Neu N, Pajk W, Fischer V, Treml B, Stein JI, Loeckinger A (2008) Intravenous tezosentan improves gas exchange and hemodynamics in acute lung injury secondary to meconium aspiration. Intensive Care Med 34:368\u2013376","journal-title":"Intensive Care Med"},{"key":"2484_CR14","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1097\/01.CCM.0000126262.23422.F0","volume":"32","author":"D Konrad","year":"2004","unstructured":"Konrad D, Oldner A, Rossi P, Wanecek M, Rudehill A, Weitzberg E (2004) Differentiated and dose-related cardiovascular effects of a dual endothelin receptor antagonist in endotoxin shock. Crit Care Med 32:1192\u20131199","journal-title":"Crit Care Med"},{"key":"2484_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/01.PCC.0000137357.52609.F0","volume":"5","author":"RK Fitzgerald","year":"2004","unstructured":"Fitzgerald RK, Oishi P, Ovadia B, Ross GA, Reinhartz O, Johengen MJ, Fineman JR (2004) Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension. Pediatr Crit Care Med 5:571\u2013577","journal-title":"Pediatr Crit Care Med"},{"key":"2484_CR16","doi-asserted-by":"crossref","first-page":"H1587","DOI":"10.1152\/ajpheart.01004.2005","volume":"291","author":"AP Lourenco","year":"2006","unstructured":"Lourenco AP, Roncon-Albuquerque R, Jr., Bras-Silva C, Faria B, Wieland J, Henriques-Coelho T, Correia-Pinto J, Leite-Moreira AF (2006) Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats. Am J Physiol Heart Circ Physiol 291:H1587\u20131594. Epub 2006 May 1585","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2484_CR17","doi-asserted-by":"crossref","first-page":"H1528","DOI":"10.1152\/ajpheart.01031.2005","volume":"290","author":"CT Gan","year":"2006","unstructured":"Gan CT, Lankhaar JW, Marcus JT, Westerhof N, Marques KM, Bronzwaer JG, Boonstra A, Postmus PE, Vonk-Noordegraaf A (2006) Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol 290:H1528\u20131533","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2484_CR18","first-page":"195","volume":"174","author":"YL Lai","year":"1996","unstructured":"Lai YL, Thacker AA, Diana JN (1996) Hypoxemia and elevated tachykinins in rat monocrotaline pneumotoxicity. Lung 174:195\u2013203","journal-title":"Lung"},{"key":"2484_CR19","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1161\/HYPERTENSIONAHA.109.133397","volume":"54","author":"A Csiszar","year":"2009","unstructured":"Csiszar A, Labinskyy N, Olson S, Pinto JT, Gupte S, Wu JM, Hu F, Ballabh P, Podlutsky A, Losonczy G, de Cabo R, Mathew R, Wolin MS, Ungvari Z (2009) Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats. Hypertension 54:668\u2013675","journal-title":"Hypertension"},{"key":"2484_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/HJH.0b013e328332bcdb","volume":"28","author":"P Crosswhite","year":"2010","unstructured":"Crosswhite P, Sun Z (2010) Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension. J Hypertens 28:201\u2013212","journal-title":"J Hypertens"},{"key":"2484_CR21","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.cardiores.2003.09.023","volume":"60","author":"E Hironaka","year":"2003","unstructured":"Hironaka E, Hongo M, Sakai A, Mawatari E, Terasawa F, Okumura N, Yamazaki A, Ushiyama Y, Yazaki Y, Kinoshita O (2003) Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats. Cardiovasc Res 60:692\u2013699","journal-title":"Cardiovasc Res"},{"key":"2484_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/HYPERTENSIONAHA.107.091348","volume":"50","author":"T Ito","year":"2007","unstructured":"Ito T, Okada T, Mimuro J, Miyashita H, Uchibori R, Urabe M, Mizukami H, Kume A, Takahashi M, Ikeda U, Sakata Y, Shimada K, Ozawa K (2007) Adenoassociated virus-mediated prostacyclin synthase expression prevents pulmonary arterial hypertension in rats. Hypertension 50:531\u2013536","journal-title":"Hypertension"},{"key":"2484_CR23","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/j.1538-7836.2010.03742.x","volume":"8","author":"F Santilli","year":"2010","unstructured":"Santilli F, Davi G, Basili S, Lattanzio S, Cavoni A, Guizzardi G, De Feudis L, Traisci G, Pettinella C, Paloscia L, Minuz P, Meneguzzi A, Ciabattoni G, Patrono C (2010) Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. J Thromb Haemost 8:914\u2013922","journal-title":"J Thromb Haemost"},{"key":"2484_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1056\/NEJM199207093270202","volume":"327","author":"BW Christman","year":"1992","unstructured":"Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Loyd JE (1992) An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 327:70\u201375","journal-title":"N Engl J Med"},{"key":"2484_CR25","doi-asserted-by":"crossref","first-page":"L316","DOI":"10.1152\/ajplung.00228.2002","volume":"284","author":"CD Fike","year":"2003","unstructured":"Fike CD, Kaplowitz MR, Pfister SL (2003) Arachidonic acid metabolites and an early stage of pulmonary hypertension in chronically hypoxic newborn pigs. Am J Physiol Lung Cell Mol Physiol 284:L316\u2013323","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2484_CR26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbadis.2006.09.002","volume":"1772","author":"M Elahi","year":"2007","unstructured":"Elahi M, Asopa S, Matata B (2007) NO-cGMP and TNF-alpha counter regulatory system in blood: understanding the mechanisms leading to myocardial dysfunction and failure. Biochim Biophys Acta 1772:5\u201314","journal-title":"Biochim Biophys Acta"},{"key":"2484_CR27","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1161\/01.CIR.102.22.2758","volume":"102","author":"U Grandel","year":"2000","unstructured":"Grandel U, Fink L, Blum A, Heep M, Buerke M, Kraemer HJ, Mayer K, Bohle RM, Seeger W, Grimminger F, Sibelius U (2000) Endotoxin-induced myocardial tumor necrosis factor-alpha synthesis depresses contractility of isolated rat hearts: evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production. Circulation 102:2758\u20132764","journal-title":"Circulation"},{"key":"2484_CR28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.CIR.98.2.100","volume":"98","author":"SC Wong","year":"1998","unstructured":"Wong SC, Fukuchi M, Melnyk P, Rodger I, Giaid A (1998) Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. Circulation 98:100\u2013103","journal-title":"Circulation"},{"key":"2484_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ijcard.2011.05.078","volume":"154","author":"CZ Shi","year":"2012","unstructured":"Shi CZ, Zhang XP, Lv ZW, Zhang HL, Xu JZ, Yin ZF, Yan YQ, Wang CQ (2012) Adipose tissue-derived stem cells embedded with eNOS restore cardiac function in acute myocardial infarction model. Int J Cardiol 154:2\u20138","journal-title":"Int J Cardiol"},{"key":"2484_CR30","doi-asserted-by":"publisher","first-page":"H1600","DOI":"10.1152\/ajpheart.01108.2009","volume":"298","author":"JD Miller","year":"2010","unstructured":"Miller JD, Peotta VA, Chu Y, Weiss RM, Zimmerman K, Brooks RM, Heistad DD (2010) MnSOD protects against COX1-mediated endothelial dysfunction in chronic heart failure. Am J Physiol Heart Circ Physiol 298:H1600\u20131607","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2484_CR31","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1161\/01.CIR.0000053443.27512.33","volume":"107","author":"B Rondelet","year":"2003","unstructured":"Rondelet B, Kerbaul F, Motte S, van Beneden R, Remmelink M, Brimioulle S, McEntee K, Wauthy P, Salmon I, Ketelslegers JM, Naeije R (2003) Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension. Circulation 107:1329\u20131335","journal-title":"Circulation"},{"key":"2484_CR32","first-page":"967","volume":"231","author":"M Clozel","year":"2006","unstructured":"Clozel M, Hess P, Rey M, Iglarz M, Binkert C, Qiu C (2006) Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats. Exp Biol Med (Maywood) 231:967\u2013973","journal-title":"Exp Biol Med (Maywood)"},{"key":"2484_CR33","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1164\/rccm.200412-1684OC","volume":"172","author":"RE Girgis","year":"2005","unstructured":"Girgis RE, Champion HC, Diette GB, Johns RA, Permutt S, Sylvester JT (2005) Decreased exhaled nitric oxide in pulmonary arterial hypertension: response to bosentan therapy. Am J Respir Crit Care Med 172:352\u2013357","journal-title":"Am J Respir Crit Care Med"},{"key":"2484_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0735-1097(01)01692-8","volume":"39","author":"M Clozel","year":"2002","unstructured":"Clozel M, Qiu C, Qiu CS, Hess P, Clozel JP (2002) Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarction. J Am Coll Cardiol 39:142\u2013147","journal-title":"J Am Coll Cardiol"},{"key":"2484_CR35","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/08860220600583690","volume":"28","author":"N Aravindan","year":"2006","unstructured":"Aravindan N, Cata JP, Dougherty PM, Shaw AD (2006) Effect of fenoldopam on ischemia\/reperfusion-induced apoptosis. Ren Fail 28:337\u2013344","journal-title":"Ren Fail"},{"key":"2484_CR36","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/emm.2007.67","volume":"39","author":"K Gamze","year":"2007","unstructured":"Gamze K, Mehmet HM, Deveci F, Turgut T, Ilhan F, Ozercan I (2007) Effect of bosentan on the production of proinflammatory cytokines in a rat model of emphysema. Exp Mol Med 39:614\u2013620","journal-title":"Exp Mol Med"},{"key":"2484_CR37","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1124\/mol.64.4.923","volume":"64","author":"M Woods","year":"2003","unstructured":"Woods M, Wood EG, Bardswell SC, Bishop-Bailey D, Barker S, Wort SJ, Mitchell JA, Warner TD (2003) Role for nuclear factor-kappaB and signal transducer and activator of transcription 1\/interferon regulatory factor-1 in cytokine-induced endothelin-1 release in human vascular smooth muscle cells. Mol Pharmacol 64:923\u2013931","journal-title":"Mol Pharmacol"},{"key":"2484_CR38","doi-asserted-by":"publisher","first-page":"4670","DOI":"10.1158\/1078-0432.CCR-04-0315","volume":"10","author":"F Spinella","year":"2004","unstructured":"Spinella F, Rosano L, Di Castro V, Nicotra MR, Natali PG, Bagnato A (2004) Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells. Clin Cancer Res 10:4670\u20134679","journal-title":"Clin Cancer Res"},{"key":"2484_CR39","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1006\/jmcc.1998.0898","volume":"31","author":"RJ Hendrickson","year":"1999","unstructured":"Hendrickson RJ, Cappadona C, Yankah EN, Sitzmann JV, Cahill PA, Redmond EM (1999) Sustained pulsatile flow regulates endothelial nitric oxide synthase and cyclooxygenase expression in co-cultured vascular endothelial and smooth muscle cells. J Mol Cell Cardiol 31:619\u2013629","journal-title":"J Mol Cell Cardiol"},{"key":"2484_CR40","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1007\/s00134-011-2254-9","volume":"37","author":"M Revermann","year":"2011","unstructured":"Revermann M, Schloss M, Mieth A, Babelova A, Schroder K, Neofitidou S, Buerkl J, Kirschning T, Schermuly RT, Hofstetter C, Brandes RP (2011) Levosimendan attenuates pulmonary vascular remodeling. Intensive Care Med 37:1368\u20131377","journal-title":"Intensive Care Med"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-012-2484-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-012-2484-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-012-2484-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-012-2484-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T03:42:04Z","timestamp":1744170124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-012-2484-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,14]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["2484"],"URL":"https:\/\/doi.org\/10.1007\/s00134-012-2484-5","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,14]]},"assertion":[{"value":"21 August 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}